Improved demand from U.S. clients helped all eight business segments at Infosys post higher growth, with its mainstay ...

Revenue forecast refers to the process of estimating the amount of revenue a business is likely to generate over a specific future period. It is typically based on historical data, market ...

Infosys, India's second-largest IT services provider, reported better-than-expected third-quarter revenue on Thursday, aided ...

Evoke, formally known as 888 holdings, expects its full-year 2024 adjusted earnings before interest, taxes, depreciation, and amortization to be at the high end of the previously guided range of 300 ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Taiwan Semiconductor Manufacturing Co logged record quarterly profit on Thursday and said it expects robust revenue growth in ...

Vietnam Maritime Corp., undaunted by potential tariffs from the incoming Trump administration that risk crimping the nation’s ...

Indian tech giant Infosys hiked its annual sale forecast Thursday and posted an 11.4 percent on-year rise in profit for the December quarter, signalling a gradual revival in client spending.

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...

In a report released yesterday, Daniel Clark from Leerink Partners maintained a Buy rating on Zoetis (ZTS – Research Report), with a price ...